Selenium nanoparticles from HM1 capable of antagonizing animal pathogenic fungi as a new source from human breast milk.

The current study was performed to develop a simple, safe, and cost-effective technique for the biosynthesis of selenium nanoparticles (SeNPs) from lactic acid bacteria (LAB) isolated from human breast milk with antifungal activity against animal pathogenic fungi. The LAB was selected based on their speed of transforming sodium selenite (NaSeO) to SeNPs. Out of the four identified LAB isolates, only one strain produced dark red color within 32 h of incubation, indicating that this isolate was the fastest in transforming NaSeO to SeNPs; and was chosen for the biosynthesis of LAB-SeNPs.

The use of biological selenium nanoparticles to suppress L. crown and root rot diseases induced by species and improve yield under drought and heat stress.

species threaten wheat crops around the world and cause global losses. The global trend is toward using biological materials such as selenium (Se) in nano form to control these fungi. Bulk selenium is toxic and harmful at high doses; however, selenium nanoparticles are safe; therefore, the aim of this study to employ the biological selenium nanoparticles (BioSeNPs) synthesized by ML14 in controlling wheat crown and root rot diseases (CRDs) induced by spp.